Investor Webinar 20 May 2022
In this week’s Investor Webinar: – We launched the first 3 Concierge trades. – What…
Pivotal Systems (ASX:PVS): Interview with incoming CEO Kevin Hill
Pivotal Systems (ASX:PVS) We spoke with Pivotal Systems‘ (ASX:PVS) incoming CEO, Kevin Hill, about the unique…
Investor Webinar 6 May 2022
In this week’s Investor Webinar: – Stocks Down Under Concierge is here! – What to…
Interview with Black Rock Mining (ASX:BKT) MD John de Vries
Black Rock Mining (ASX: BKT) We spoke to John de Vries, Managing Director of Black Rock…
Interview with Artrya (ASX: AYA) MD John Barrington
Artrya (ASX: AYA) We spoke with John Barrington, Managing Director of Artrya (ASX: AYA) about the…
Investor Webinar 20 April 2022
In this week’s Investor Webinar: – Helium play Blue Star Helium (ASX:BNL) – An update…
Investor Webinar 13 April 2022
In this week’s Investor Webinar: – How about a slice of Domino’s Pizza (ASX:DMP) –…
Kinetiko Energy (ASX:KKO): Interview with Chairman Adam Sierakowski
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER Kinetiko Energy (ASX:KKO) We spoke to…
Investor Webinar 7 April 2022
In this week’s Investor Webinar: – We answer subcriber questions about Geopacific Resources (ASX:GPR) and…
Skin Elements (ASX:SKN): Interview with Chairman Peter Malone
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER Skin Elements We spoke to Peter…
Finexia Financial Group (ASX:FNX) interview with MD Neil Sheather
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER Finexia Financial Group We spoke to…
Friday Beers with Marc & Stuart: Make money, not war!
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER In this episode of Friday Beers…
Clarity Pharmaceuticals (ASX:CU6) presents at our Meet the CEO event, 3 March 2022
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER Clarity Pharmaceuticals Dr. Alan Taylor, CEO…
Memphasys (ASX:MEM) at Meet the CEO, Life Sciences 3 March 2022
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER Memphasys On 3 March 2022,…
Nyrada (ASX:NYR) CEO James Bonner presenting at Meet the CEO
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER Nyrada On 3 March James…
Recce Pharmaceuticals (ASX:RCE) CEO James Graham presenting at Meet the CEO
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER Recce Pharmaceuticals CEO James Graham presneted…